A Mortality Prediction Score for Patients With Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO): The PREDICT VV-ECMO Score.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
pubmed:
7
11
2023
medline:
7
11
2023
entrez:
7
11
2023
Statut:
aheadofprint
Résumé
Mortality prediction for patients with the severe acute respiratory distress syndrome (ARDS) supported with veno-venous extracorporeal membrane oxygenation (VV-ECMO) is challenging. Clinical variables at baseline and on day 3 after initiation of ECMO support of all patients treated from October 2010 through April 2020 were analyzed. Multivariate logistic regression analysis was used to identify score variables. Internal and external (Monza, Italy) validation was used to evaluate the predictive value of the model. Overall, 272 patients could be included for data analysis and creation of the PREDICT VV-ECMO score. The score comprises five parameters (age, lung fibrosis, immunosuppression, cumulative fluid balance, and ECMO sweep gas flow on day 3). Higher score values are associated with a higher probability of hospital death. The score showed favorable results in derivation and external validation cohorts (area under the receiver operating curve, AUC derivation cohort 0.76 [95% confidence interval, CI, 0.71-0.82] and AUC validation cohort 0.74 [95% CI, 0.67-0.82]). Four risk classes were defined: I ≤ 30, II 31-60, III 61-90, and IV ≥ 91 with a predicted mortality of 28.2%, 56.2%, 84.8%, and 96.1%, respectively. The PREDICT VV-ECMO score suggests favorable performance in predicting hospital mortality under ongoing ECMO support providing a sound basis for further evaluation in larger cohorts.
Identifiants
pubmed: 37934747
doi: 10.1097/MAT.0000000000002088
pii: 00002480-990000000-00339
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASAIO.
Déclaration de conflit d'intérêts
Disclosure: J.R. has received a research grant from Philipps and Abbott, independent from this work. A.S. has received speaker’s honoraria from CytoSorbents and Abiomed and a research grant from CytoSorbens, independent from this work. The other authors have no conflicts of interest to report.
Références
Peek GJ, Mugford M, Tiruvoipati R, et al.: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 374: 1351–1363, 2009.
Combes A, Hajage D, Capellier G, et al.: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378: 1965–1975, 2018.
Rilinger J, Krötzsch K, Bemtgen X, et al.: Long-term survival and health-related quality of life in patients with severe acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation support. Crit Care 25: 410, 2021.
Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E: Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis. Lancet Respir Med 7: 163–172, 2019.
Combes A, Peek GJ, Hajage D, et al.: ECMO for severe ARDS: Systematic review and individual patient data meta-analysis. Intensive Care Med 46: 2048–2057, 2020.
Goligher EC, Tomlinson G, Hajage D, et al.: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA 320: 2251, 2018.
Karagiannidis C, Brodie D, Strassmann S, et al.: Extracorporeal membrane oxygenation: Evolving epidemiology and mortality. Intensive Care Med 42: 889–896, 2016.
Extracorporeal Life Support Organization (ELSO): 2020 Annual Report. Accessed 21 Feb 2022. https://www.elso.org/Portals/0/Files/pdf/ELSO%20Annual%20Report%202020%20PRODUCED.pdf .
Barbaro RP, MacLaren G, Boonstra PS, et al.: Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020: 1071, 2020.
Barbaro RP, MacLaren G, Boonstra PS, et al.: Extracorporeal membrane oxygenation for COVID-19: Evolving outcomes from the international extracorporeal life support organization registry. Lancet 398: 1230–1238, 2021.
Schmidt M, Zogheib E, Roze H, et al.: The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 39: 1704–1713, 2013.
Schmidt M, Bailey M, Sheldrake J, et al.: Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 189: 1374–1382, 2014.
Pappalardo F, Pieri M, Greco T, et al.; Italian ECMOnet: Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: The ECMOnet score. Intensive Care Med 39: 275–281, 2013.
Hilder M, Herbstreit F, Adamzik M, et al.: Comparison of mortality prediction models in acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation and development of a novel prediction score: the PREdiction of Survival on ECMO Therapy-Score (PRESET-Score). Crit Care 21: 301, 2017.
Roch A, Hraiech S, Masson E, et al.: Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med 40: 74–83, 2014.
Benchimol EI, Smeeth L, Guttmann A, et al.: The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med 12: e1001885, 2015.
Force ADT, Ranieri VM, Rubenfeld GD, et al.: Acute respiratory distress syndrome: The Berlin Definition. JAMA 307: 2526–2533, 2012.
Tonna JE, Abrams D, Brodie D, et al.: Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): Guideline from the extracorporeal life support organization (ELSO). ASAIO J 67: 601–610, 2021.
Gottlieb J, Capetian P, Hamsen U, et al.: German S3 guideline: Oxygen therapy in the acute care of adult patients. Respiration 101: 214–252, 2022.
Abrams D, Ferguson ND, Brochard L, et al.: ECMO for ARDS: From salvage to standard of care? Lancet Respir Med 7: 108–110, 2019.
Staudacher DL, Gold W, Biever PM, Bode C, Wengenmayer T: Early fluid resuscitation and volume therapy in venoarterial extracorporeal membrane oxygenation. J Crit Care 37: 130–135, 2017.
Combes A, Schmidt M, Hodgson CL, et al.: Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Med 46: 2464–2476, 2020.
Schmidt M, Pham T, Arcadipane A, et al.: Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome An international multicenter prospective cohort. Am J Respir Crit Care Med 2019: 1002, 1012.
Rilinger J, Zotzmann V, Bemtgen X, et al.: Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation. Crit Care 24: 397, 2020.
Schmidt M, Schellongowski P, Patroniti N, et al.: Six-month outcome of immunocompromised patients with severe acute respiratory distress syndrome rescued by extracorporeal membrane oxygenation an international multicenter retrospective study. Am J Respir Crit Care Med 197: 1297–1307, 2018.
Jackel M, Rilinger J, Lang CN, et al.: Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study. Artif Organs 45: 593–601, 2020.
Lazzeri C, Cianchi G, Mauri T, et al.: A novel risk score for severe ARDS patients undergoing ECMO after retrieval from peripheral hospitals. Acta Anaesthesiol Scand 62: 38–48, 2018.
Zakhary B, Fan E, Slutsky A: Should patients with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation have ventilatory support reduced to the lowest tolerable settings? Yes. Crit Care Med 47: 1143–1146, 2019.
Shekar K, Brodie D: Should patients with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation have ventilatory support reduced to the lowest tolerable settings? No. Crit Care Med 47: 1147–1149, 2019.
Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH: Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg 139: 765–773.e1, 2010.
Inci I, Klinzing S, Schneiter D, et al.: Outcome of extracorporeal membrane oxygenation as a bridge to lung transplantation: An institutional experience and literature review. Transplantation 99: 1667–1671, 2015.
Rilinger J, Zotzmann V, Bemtgen X, et al.: Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno-venous extracorporeal membrane oxygenation therapy. Artif Organs 1050–1060, 2021.
Swets JA: Measuring the accuracy of diagnostic systems. Science 240: 1285–1293, 1988.
Raith EP, Udy AA, Bailey M, et al.; Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE): Prognostic accuracy of the SOFA Score, SIRS criteria, and qSOFA Score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 317: 290–300, 2017.